[Hyperglycemia, morbidity and mortality in critically ill children: critical analysis based on a systematic review]

Eduardo Mekitarian Filho1, Werther Brunow de Carvalho, Eduardo Juan Troster

  • 1Instituto da Criança Professor Pedro de Alcântara da Universidade de São Paulo, S. Paulo, Brazil. emf2002@uol.com.br

Revista Da Associacao Medica Brasileira (1992)
|September 15, 2009
PubMed

Insights

Hyperglycemia in critically ill children admitted to the pediatric intensive care unit (PICU) is linked to increased morbidity and mortality. Further prospective studies are needed to confirm these findings and address methodological limitations.

Area of Science:

  • Pediatric Critical Care Medicine
  • Endocrinology
  • Clinical Research Methodology

Background:

  • Hyperglycemia is a common metabolic derangement in critically ill pediatric patients.
  • The impact of hyperglycemia on morbidity and mortality in this population requires thorough investigation.

Purpose of the Study:

  • To determine if hyperglycemia is a risk factor for increased morbidity and mortality in critically ill pediatric patients.
  • To critically analyze existing pediatric and neonatology literature on this topic.

Main Methods:

  • Systematic literature review of Medline, Cochrane, Lilacs, and Embase databases.
  • Inclusion of cohort studies (retrospective and prospective) in Portuguese, English, and Spanish.
  • Evaluation of outcomes including PICU and hospital mortality, length of stay, infection risk, and mechanical ventilation time.

Main Results:

  • 79 articles were initially selected, with 15 cohort studies (2 prospective, 13 retrospective) analyzed.
  • Analysis of cohort studies indicated that hyperglycemia increases morbidity, mortality, and length of stay in the PICU for critically ill children.

Conclusions:

  • Hyperglycemia, whether isolated or persistent, is associated with worse outcomes in critically ill children.
  • Methodological limitations in existing studies, including glucose measurement protocols and study design, necessitate further prospective research.
  • Hyperglycemia's role as a singular predictor of morbidity and mortality in pediatrics requires additional investigation.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...